These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38140231)

  • 1. Attenuated Chimeric GI/GIII Vaccine Candidate against Japanese Encephalitis Virus.
    Lee E; Kim M; Kim YB
    Vaccines (Basel); 2023 Dec; 11(12):. PubMed ID: 38140231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial cross-protection between Japanese encephalitis virus genotype I and III in mice.
    Wei J; Wang X; Zhang J; Guo S; Pang L; Shi K; Liu K; Shao D; Qiu Y; Liu L; Widén F; Li B; Ma Z
    PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007601. PubMed ID: 31374086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virulence and Cross-Protection Conferred by an Attenuated Genotype I-Based Chimeric Japanese Encephalitis Virus Strain Harboring the E Protein of Genotype V in Mice.
    Xia Q; Zhang Y; Yang Y; Ma X; Guan Z; Zhang J; Li Z; Liu K; Li B; Shao D; Qiu Y; Wei J; Ma Z
    Microbiol Spectr; 2022 Dec; 10(6):e0199022. PubMed ID: 36301111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sero-Molecular Epidemiology of Japanese Encephalitis in Zhejiang, an Eastern Province of China.
    Pan JR; Yan JY; Zhou JY; Tang XW; He HQ; Xie RH; Mao HY; Zhang YJ; Xie SY
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004936. PubMed ID: 27560360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Envelope protein gene based molecular characterization of Japanese encephalitis virus clinical isolates from West Bengal, India: a comparative approach with respect to SA14-14-2 live attenuated vaccine strain.
    Sarkar A; Banik A; Pathak BK; Mukhopadhyay SK; Chatterjee S
    BMC Infect Dis; 2013 Aug; 13():368. PubMed ID: 23927571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotype-specific neutralization determinants in envelope protein: implications for the improvement of Japanese encephalitis vaccine.
    Ye Q; Xu YP; Zhang Y; Li XF; Wang HJ; Liu ZY; Li SH; Liu L; Zhao H; Nian QG; Deng YQ; Qin ED; Qin CF
    J Gen Virol; 2015 Aug; 96(8):2165-2175. PubMed ID: 25908779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic Determinants of Japanese Encephalitis Virus Vaccine Strain SA14-14-2 That Govern Attenuation of Virulence in Mice.
    Gromowski GD; Firestone CY; Whitehead SS
    J Virol; 2015 Jun; 89(12):6328-37. PubMed ID: 25855730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction and immune efficacy of recombinant pseudorabies virus expressing PrM-E proteins of Japanese encephalitis virus genotype І.
    Qian P; Zhi X; Wang B; Zhang H; Chen H; Li X
    Virol J; 2015 Dec; 12():214. PubMed ID: 26651827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shift in dominant genotypes of Japanese encephalitis virus and its impact on current vaccination strategies.
    Xia Q; Yang Y; Zhang Y; Zhou L; Ma X; Xiao C; Zhang J; Li Z; Liu K; Li B; Shao D; Qiu Y; Wei J; Ma Z
    Front Microbiol; 2023; 14():1302101. PubMed ID: 38045034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity and Protective Ability of Genotype I-Based Recombinant Japanese Encephalitis Virus (JEV) with Attenuation Mutations in E Protein against Genotype V JEV.
    Tajima S; Taniguchi S; Nakayama E; Maeki T; Inagaki T; Saijo M; Lim CK
    Vaccines (Basel); 2021 Sep; 9(10):. PubMed ID: 34696184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamics of the emergence and establishment of a newly dominant genotype of Japanese encephalitis virus throughout Asia.
    Schuh AJ; Ward MJ; Leigh Brown AJ; Barrett AD
    J Virol; 2014 Apr; 88(8):4522-32. PubMed ID: 24501419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced neutralizing antibody titer against genotype I virus in swine immunized with a live-attenuated genotype III Japanese encephalitis virus vaccine.
    Fan YC; Chen JM; Chen YY; Lin JW; Chiou SS
    Vet Microbiol; 2013 May; 163(3-4):248-56. PubMed ID: 23415032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chimeric Japanese Encephalitis Virus SA14/SA14-14-2 Was Virulence Attenuated and Protected the Challenge of Wild-Type Strain SA14.
    Huang R; Leng S; Feng Y; Tang L; Yuan L; Yang J
    Can J Infect Dis Med Microbiol; 2019; 2019():9179308. PubMed ID: 30944684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular Immune Responses to Live Attenuated Japanese Encephalitis (JE) Vaccine SA14-14-2 in Adults in a JE/Dengue Co-Endemic Area.
    Turtle L; Tatullo F; Bali T; Ravi V; Soni M; Chan S; Chib S; Venkataswamy MM; Fadnis P; Yaïch M; Fernandez S; Klenerman P; Satchidanandam V; Solomon T
    PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005263. PubMed ID: 28135273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel amino acid site closely associated with the neurovirulence of live, attenuated Japanese encephalitis vaccine (SA14-14-2 strain).
    Yang H; Fan F; Liu L; Liu J; Sun Y; Xie A; Shi X; Liu L; Yu Y; Li Y; Ge Y; Zeng X; Yang H
    Vaccine; 2020 Mar; 38(11):2636-2642. PubMed ID: 32044162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of Live-Attenuated Genotype III Japanese Encephalitis Viral Vaccine against Circulating Genotype I Viruses in Swine.
    Fan YC; Chen YY; Chen JM; Huang C; Huang M; Chiou SS
    Viruses; 2022 Jan; 14(1):. PubMed ID: 35062317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular basis for attenuation of neurovirulence of a yellow fever Virus/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE).
    Arroyo J; Guirakhoo F; Fenner S; Zhang ZX; Monath TP; Chambers TJ
    J Virol; 2001 Jan; 75(2):934-42. PubMed ID: 11134306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotype I of Japanese Encephalitis Virus Virus-like Particles Elicit Sterilizing Immunity against Genotype I and III Viral Challenge in Swine.
    Fan YC; Chen JM; Lin JW; Chen YY; Wu GH; Su KH; Chiou MT; Wu SR; Yin JH; Liao JW; Chang GJ; Chiou SS
    Sci Rep; 2018 May; 8(1):7481. PubMed ID: 29748549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partially neutralizing potency against emerging genotype I virus among children received formalin-inactivated Japanese encephalitis virus vaccine.
    Fan YC; Chen JM; Chiu HC; Chen YY; Lin JW; Shih CC; Chen CM; Chang CC; Chang GJ; Chiou SS
    PLoS Negl Trop Dis; 2012; 6(9):e1834. PubMed ID: 23029592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel reverse genetics of genotype I and III Japanese encephalitis viruses assembled through transformation associated recombination in yeast: The reporter viruses expressing a green fluorescent protein for the antiviral screening assay.
    Li C; Chen X; Zhou Y; Hu J; Wang X; Li Y
    Antiviral Res; 2022 Jan; 197():105233. PubMed ID: 34973281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.